EndoFold Overview
- Year Founded
-
2024
- Status
-
Out of Business
- Employees
-
9
- Latest Deal Type
-
Out of Business
EndoFold General Information
Description
Developer of a gene delivery platform designed to deliver genetic material for the treatment of cancer, immune, and musculoskeletal diseases. The company offers human protein-based RNA carriers, a computational testing platform, and targeted delivery methods, enabling biotech researchers to develop non-viral therapies with reduced immune activation.
Contact Information
Website
www.endofold.bioCorporate Office
- 2030 47th Avenue
- San Francisco, CA 94116
- United States
Corporate Office
- 2030 47th Avenue
- San Francisco, CA 94116
- United States
EndoFold Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 22-Sep-2026 | Completed | Out of Business | |||
| 2. Early Stage VC | 01-Mar-2025 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
EndoFold Signals
EndoFold FAQs
-
When was EndoFold founded?
EndoFold was founded in 2024.
-
Where is EndoFold headquartered?
EndoFold is headquartered in San Francisco, CA.
-
What is the size of EndoFold?
EndoFold has 9 total employees.
-
What industry is EndoFold in?
EndoFold’s primary industry is Drug Delivery.
-
Is EndoFold a private or public company?
EndoFold is a Private company.
-
What is EndoFold’s current revenue?
The current revenue for EndoFold is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process